These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 37055842)
1. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer. Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842 [TBL] [Abstract][Full Text] [Related]
2. Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition. Lu L; Gao Y; Huang D; Liu H; Yin D; Li M; Zheng J; Wang S; Wu W; Zhao L; Bi D; Zhang Y; Song F; Xie R; Wang J; Qin H; Wei Q J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040421 [TBL] [Abstract][Full Text] [Related]
3. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094 [No Abstract] [Full Text] [Related]
4. CD8 Zheng X; Jiang K; Xiao W; Zeng D; Peng W; Bai J; Chen X; Li P; Zhang L; Zheng X; Miao Q; Wang H; Wu S; Xu Y; Xu H; Li C; Li L; Gao X; Zheng S; Li J; Wang D; Zhou Z; Xia X; Yang S; Li Y; Cui Z; Zhang Q; Chen L; Lin X; Lin G Front Immunol; 2022; 13():974265. PubMed ID: 36439099 [TBL] [Abstract][Full Text] [Related]
5. CXCL5 impedes CD8 Sun D; Tan L; Chen Y; Yuan Q; Jiang K; Liu Y; Xue Y; Zhang J; Cao X; Xu M; Luo Y; Xu Z; Xu Z; Xu W; Shen M J Exp Clin Cancer Res; 2024 Jul; 43(1):202. PubMed ID: 39034411 [TBL] [Abstract][Full Text] [Related]
6. Endostatin induces normalization of blood vessels in colorectal cancer and promotes infiltration of CD8+ T cells to improve anti-PD-L1 immunotherapy. Chu XD; Bao H; Lin YJ; Chen RX; Zhang YR; Huang T; He JS; Huangfu SC; Pan YL; Ding H Front Immunol; 2022; 13():965492. PubMed ID: 36389685 [TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer. Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405 [No Abstract] [Full Text] [Related]
8. CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis. Zhou X; Meng F; Xiao L; Shen H BMC Med Genomics; 2023 Oct; 16(1):228. PubMed ID: 37784135 [TBL] [Abstract][Full Text] [Related]
9. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma. Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072 [TBL] [Abstract][Full Text] [Related]
10. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141 [TBL] [Abstract][Full Text] [Related]
11. Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment. Cheng CC; Chang J; Ho AS; Sie ZL; Peng CL; Wang CL; Dev K; Chang CC Cancer Immunol Immunother; 2024 Jul; 73(9):175. PubMed ID: 38953994 [TBL] [Abstract][Full Text] [Related]
12. Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. Zhang X; Lao M; Xu J; Duan Y; Yang H; Li M; Ying H; He L; Sun K; Guo C; Chen W; Jiang H; Zhang X; Bai X; Liang T J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35260434 [TBL] [Abstract][Full Text] [Related]
13. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma. Gao ZX; Zhang ZS; Qin J; Zhang MZ; Cao JL; Li YY; Wang MQ; Hou LL; Fang D; Xie SQ Phytomedicine; 2023 Apr; 112():154715. PubMed ID: 36821999 [TBL] [Abstract][Full Text] [Related]
14. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells. Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928 [TBL] [Abstract][Full Text] [Related]
15. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer. Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281 [TBL] [Abstract][Full Text] [Related]
16. Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination. Sun Z; Mai H; Xue C; Fan Z; Li J; Chen H; Huo N; Kang X; Tang C; Fang L; Zhao H; Han Y; Sun C; Peng H; Du Y; Yang J; Du N; Xu X J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040417 [TBL] [Abstract][Full Text] [Related]
17. PD-L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer. Miller TJ; Anyaegbu CC; Lee-Pullen TF; Spalding LJ; Platell CF; McCoy MJ Cancer Sci; 2021 Mar; 112(3):1173-1183. PubMed ID: 33345422 [TBL] [Abstract][Full Text] [Related]
18. Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses. Lan Y; Yeung TL; Huang H; Wegener AA; Saha S; Toister-Achituv M; Jenkins MH; Chiu LY; Lazorchak A; Tarcic O; Wang H; Qi J; Locke G; Kalimi D; Qin G; Marelli B; Yu H; Gross AW; Derner MG; Soloviev M; Botte M; Sircar A; Ma H; Sood VD; Zhang D; Jiang F; Lo KM J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35858707 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the transcriptomic features of microsatellite instability subtype colon cancer. Wang H; Wang X; Xu L; Zhang J; Cao H BMC Cancer; 2019 Jun; 19(1):605. PubMed ID: 31221124 [TBL] [Abstract][Full Text] [Related]
20. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice. Li N; Tang J; Yang J; Zhu B; Wang X; Luo Y; Yang H; Jang F; Zou J; Liu Z; Wang Z Cancer Lett; 2021 Feb; 498():121-129. PubMed ID: 33129956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]